Geographic · Operating Income

Asia Pacific — Operating Income

Zimmer Biomet Holdings Asia Pacific — Operating Income decreased by 20.6% to $93.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $88.80M to $93.00M. Over 4 years (FY 2021 to FY 2025), Asia Pacific — Operating Income shows relatively stable performance with a 1.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Rolls up toOperating Income

How to read this metric

Higher operating income indicates strong regional profitability and effective cost management.

Detailed definition

The profit or loss generated by the Asia Pacific segment after deducting cost of goods sold, SG&A, and R&D expenses from...

Peer comparison

Standard segment-level profitability metric for all public companies.

Metric ID: zbh_segment_asia_pacific_operating_income_loss

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$105.50M$106.70M$92.40M$93.40M$110.00M$103.60M$118.90M$90.20M$115.30M$112.50M$119.00M$94.40M$122.20M$123.40M$122.10M$88.80M$122.90M$116.60M$117.20M$93.00M
QoQ Change+1.1%-13.4%+1.1%+17.8%-5.8%+14.8%-24.1%+27.8%-2.4%+5.8%-20.7%+29.4%+1.0%-1.1%-27.3%+38.4%-5.1%+0.5%-20.6%
YoY Change+4.3%-2.9%+28.7%-3.4%+4.8%+8.6%+0.1%+4.7%+6.0%+9.7%+2.6%-5.9%+0.6%-5.5%-4.0%+4.7%
Range$88.80M$123.40M
CAGR-2.6%
Avg YoY Growth+3.3%
Median YoY Growth+3.4%

Frequently Asked Questions

What is Zimmer Biomet Holdings's asia pacific — operating income?
Zimmer Biomet Holdings (ZBH) reported asia pacific — operating income of $93.00M in Q1 2026.
How has Zimmer Biomet Holdings's asia pacific — operating income changed year-over-year?
Zimmer Biomet Holdings's asia pacific — operating income increased by 4.7% year-over-year, from $88.80M to $93.00M.
What is the long-term trend for Zimmer Biomet Holdings's asia pacific — operating income?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's asia pacific — operating income has grown at a 1.5% compound annual growth rate (CAGR), from $419.20M to $445.50M.
What does asia pacific — operating income mean?
The operating profit or loss earned by the Asia Pacific business segment.